Structure | Standardized nomenclature | Dosimetric Parameter | Per Protocol | Acceptable Variation |
---|---|---|---|---|
PTV_19 | PTV_19 | D98% (Dnear min) | ≥ 95% (i.e. 18 Gy) | |
D2% (Dnear max) | ≤ 107% (ie. 20.3Gy) | D5% ≤ 107%, D2% ≤ 110% | ||
Rectal_wall | Rectal_wall | V9.5Gy (50%) | < 40% | 40–50% |
V15Gy (80%) | < 15% | 15–20% | ||
V17Gy (90%) (NTD 68 Gy) | < 10% | < 15% | ||
V19Gy (100%) (NTD 83.6 Gy) | < 5% | < 10% | ||
V20Gy (105%) (NTD 92 Gy) | < 1 cc | |||
Bladder_wall | Bladder_wall | V9.5Gy (50%) | < 50% | 50–60% |
V15Gy (80%) | < 20% | 20–30% | ||
V17Gy (90%) (NTD 68 Gy) | < 15% | 15–20% | ||
V19Gy (100%) (NTD 83.6 Gy) | < 10% | < 15% | ||
V20Gy (105%) (NTD 92 Gy) | < 1 cc | |||
Femurs (each) | Femur_Rt Femur_Lt | V14Gy (NTD 48 Gy) | < 5% | 5–10% |
Penile bulb | Penile_bulb | V14Gy (NTD 48 Gy) | < 5% | 5–10% |
Urethra PRV | Urethra_PRV | D98% (Dnear min) | ≥ 95% (i.e. 16.2 Gy) | |
D5% | ≤ 107% (i.e. 18.2 Gy) | |||
D2% (Dnear max) | ≤ 110% (i.e. 18.7 Gy) |